JLRF Award

The 2020 Japan Leukemia Research Fund Award were given to 13 researchers and 2 groups this year.

Ogimura Takashi Special Prize

Tomoya Muto
[Department of Hematology, Chiba University Hospital]
“The role of innate immune signaling in the pathogenesis of hematopoietic malignancies”

Shimizu Award

Toshihiko Imamura
[Department of Pediatrics, Kyoto Prefectural University of Medicine Graduate School of Medical Science]
“Functional analysis of IKZF1 deletion in a development of ph-like acute lymphoblastic leukemia”

Credit Saison Award

Yusuke Furukawa
[Division of Stem Cell Regulation, Jichi Medical University]
“Development of novel therapeutic agents for high-risk multiple myeloma targeting histone methyltransferase MMSET”

Ide Award

Hiroshi Kobayashi
[Research Institute, National Center for Global Health and Medicine]
“Development of gene editing methods that do not impair the function of hematopoietic stem cells”

Special Award --- Clinical Medicine Special Award(In no particular order)

Yotaro Ochi
[Department of Pathology and Tumor Biology, Kyoto University]
“Aberrant transcription and novel drug target in leukemia”

Chihaya Imai
[Department of Pediatrics, Graduate School of Medical and Dental Science, Niigata University]
“An exploratory study to investigate molecular and immunological determinants associated with efficacy of bispecific antibody blinatumomab against newly diagnosed high risk B-lineage acute lymphoblastic leukemia”

General Research Award(In no particular order)

Naoki Hosen
[Department of Hematology and Oncology, Osaka University Graduate School of Medicine]
“Development of novel CAR-T cell therapy for hematological cancer”

Satoru Miyagi
[Department of Life Science, Faculty of Medicine, Shimane University]
“The molecular function of PHF6 in normal hematopoiesis and leukemogenesis”

Minoru Takata
[Laboratory of Genome Damage Signaling, Radiation Biology Center, Graduate school of Biostudies, Kyoto University]
“Genome destabilizing mechanism in Fanconi anemia: DNA damage sensitization by SLFN11 gene leading to hematopoietic failure and leukemogenesis”

Takako Miyamura
[Department of Pediatrics, Osaka University Graduate School of Medicine]
“Nationwide survey of congenital leukemia /Elucidation of pathogenesis of congenital leukemia using genome analysis”

Akira Nishimura
[Tokyo Medical and Dental University]
“Clarification of molecular pathogenesis and development of molecular targeted therapies for myeloid/natural killer cell precursor acute leukemia”

Yuki Kagoya
[Division of Immune Response, Aichi Cancer Center Research Institute]
“Development of chimeric antigen receptor engineered T cell therapy for acute myelogenous leukemia”

Mayumi Hirayama
[Laboratory Medicine, Kumamoto University Hospital]
“Roles of RNA helicase in leukemogenesis: involvement of DDX41 gene mutation in R-loop formation and DNA damage response”

Hiromi Yamazaki
[Institute of Biomedical Research and Innovation]
“Development of a treatment for acute myeloid leukemia targeting amino acid metabolism”

Mainichi Award

[Japan Children’s Cancer Group]

Hiroyuki Ishida
[Division of Pediatric Hematology, Kyoto City Hospital]
“Phase II study of allogeneic hematopoietic cell transplantation for children with acute myeloid leukemia in first and second complete remission using fludarabine, cytarabine, melphalan and low-dose total body irradiation as conditioning regimen (AML-SCT15)”

Award Recipient List of 2019-13